You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Covid-19: Maharashtra approves Rs 634 crore for medicine purchases

The Maharashtra government has given administrative approval to purchase medicines and equipment worth Rs 633.92 crore for Covid-19 treatment, an official said on Friday

Maharashtra | Coronavirus

Press Trust of India  |  Mumbai 

Coronavirus, vaccine, covid, drugs, clinical trials

The government has

given administrative approval to purchase medicines and equipment worth Rs 633.92 crore for COVID-19 treatment, an official said on Friday.

The approval was given through a health department order issued on Thursday, the official said.

He added that the revenue of the state had declined due to the outbreak and lockdown, and those in charge of procuring the medicines and equipment with this amount must adhere to technical specifications laid down by experts.

The money should be used to buy Remdesivir medicine, RT-PCR and antigen testing kits, oxygen apparatus etc, he added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, October 02 2020. 20:51 IST